- Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
- Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
- Tango Therapeutics to Participate in Upcoming Investor Conferences
Key statistics
On Tuesday, Tango Therapeutics Inc (TNGX:NMQ) closed at 7.47, 202.43% above the 52 week low of 2.47 set on May 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.63 |
---|---|
High | 7.63 |
Low | 7.38 |
Bid | 7.35 |
Offer | 11.92 |
Previous close | 7.67 |
Average volume | 498.24k |
---|---|
Shares outstanding | 106.85m |
Free float | 92.61m |
P/E (TTM) | -- |
Market cap | 819.51m USD |
EPS (TTM) | -1.11 USD |
Data delayed at least 15 minutes, as of May 21 2024 21:15 BST.
More ▼